Literature DB >> 11376962

Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination.

A Hoffman1, D Stepensky, A Ezra, J M Van Gelder, G Golomb.   

Abstract

We investigated the influence of mode of administration on the pharmacokinetics of a clinically used bisphosphonate, pamidronate, and of suberoylbisphosphonate (SuBP), a novel bisacylphosphonate of the P-CO-(C)(n)-CO-P type, in rats. Serum drug levels and tissue disposition were determined following administration of the drugs by different modes: intravenous bolus (iso-osmotic and hypo-osmotic solutions), continuous intravenous infusion, and peroral administration. Results of the study indicate that the disposition of the bisphosphonates in soft tissue (liver, kidney and spleen) was dependent on route and rate of drug administration, and on the osmoticity of the vehicle. Consequently, main pharmacokinetic parameters (AUC, CL, and V(ss)) were influenced by the mode of drug administration, precluding accurate determination of bioavailability from AUC values. On the other hand, bone and urine bisphosphonate accumulation were considerably less dependent on mode of administration, and, therefore, are recommended for bioavailability calculation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376962     DOI: 10.1016/s0378-5173(01)00654-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules.

Authors:  P Pascaud; F Errassifi; F Brouillet; S Sarda; A Barroug; A Legrouri; C Rey
Journal:  J Mater Sci Mater Med       Date:  2014-05-01       Impact factor: 3.896

Review 2.  Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.

Authors:  Hideki Hirabayashi; Jiro Fujisaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  A pilot trial of intravenous pamidronate for chronic low back pain.

Authors:  Marco Pappagallo; Brenda Breuer; Hung-Mo Lin; James B Moberly; Julia Tai; Christopher Noto; Angela Sanchez; Paolo L Manfredi
Journal:  Pain       Date:  2013-09-21       Impact factor: 6.961

5.  Early tissue responses to zoledronate, locally delivered by bone screw, into a compromised cancellous bone site: a pilot study.

Authors:  Joerg Arnoldi; Antoine Alves; Philip Procter
Journal:  BMC Musculoskelet Disord       Date:  2014-03-23       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.